Olympiad Research’s Nu Skin NUS Stock Holding History

Olympiad Research’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,080	Closed	-$271K	–	419
2020 Q2	$271K	Buy	+7,080	New	+$227K	0.19%	142

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Olympiad Research's NUS Position: Q3 2020 in Review

Olympiad Research sold out of Nu Skin (NUS) in Q3 2020, closing a stake of 7,080 shares — an estimated $271K sold.

Olympiad Research first reported a position in NUS in Q2 2020 and held it in 1 quarter. The position peaked at $271K in Q2 2020. 251 funds tracked by Wall St. Rank hold NUS as of Q3 2020.

Olympiad Research reported no remaining Nu Skin position as of Q3 2020 after selling out during the quarter.
Olympiad Research sold 7,080 Nu Skin shares in Q3 2020, an estimated $271K.
Olympiad Research first reported a position in Nu Skin in Q2 2020 and held it in 1 quarter.
Olympiad Research's Nu Skin position peaked at $271K in Q2 2020.
251 funds tracked by Wall St. Rank held Nu Skin as of Q3 2020.

Based on Olympiad Research's 13F filing for Q3 2020, filed 2 Nov 2020.